Kenya Signs $2.5bn Health Deal with US Amid Data Concerns

Published: 05 December 2025. The English Chronicle Desk. The English Chronicle Online

Kenya has signed a landmark five-year health agreement with the United States, marking the first such pact since Donald Trump’s administration overhauled its foreign aid programme. Valued at $2.5bn (£1.9bn), the agreement is aimed at combating infectious diseases in Kenya, with similar deals expected to extend to other African nations aligned with the former president’s broader foreign policy objectives.

The government-to-government agreement is designed to enhance transparency and accountability in healthcare delivery. However, it has raised concerns that the US could gain real-time access to critical health databases, potentially including sensitive patient information. Kenya’s Health Minister Aden Duale sought to reassure the public, clarifying that “only de-identified, aggregated data” would be shared.

When Trump took office in January, he implemented a freeze on foreign aid, dismantled the US Agency for International Development (USAID), and cut billions in aid to developing countries. These measures significantly reduced the availability of essential drugs and healthcare support in many nations.

In September, the Trump administration introduced an “America First Global Health Strategy,” tying foreign aid to negotiations designed to eliminate waste and advance US priorities. Analysts suggest the Kenya deal is part of this broader strategy, reflecting an effort to strengthen US influence in African health initiatives while prioritizing oversight and efficiency.

While the deal promises substantial health benefits for Kenya, it has sparked debate about data security and national sovereignty. Critics warn that even aggregated datasets could potentially be used to monitor trends or make policy decisions impacting local healthcare systems. Supporters, however, argue that the funds and technical expertise provided by the US could help Kenya strengthen its health infrastructure, particularly in combating infectious diseases that remain a significant public health challenge.

The five-year programme is expected to finance the procurement of vaccines, the expansion of diagnostic facilities, and improved disease surveillance networks. It will also support training for healthcare workers and strengthen laboratory systems, aiming to enhance Kenya’s capacity to respond to outbreaks.

This historic agreement represents a delicate balance between receiving vital international support and safeguarding the privacy and autonomy of national health data. As Kenya navigates this new partnership, stakeholders will be closely monitoring its implementation to ensure that public health objectives are met without compromising sensitive information.